Results 1 to 10 of about 6,058,943 (256)
Erciyes Medical Journal, 2020 Objective: Allogeneic hematopoietic stem cell transplantation is a treatment with a considerable rate of complete cure in hematological disorders. Hepatic complications are common causes of morbidity and mortality affecting the survival after stem cell ...
Melih Kızıltepe +5 more
doaj +2 more sources
Hematopoietic stem cell transplantation for the management of follicular lymphoma
Stem Cells and Cloning: Advances and Applications, 2010 Chitra HosingDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USAAbstract: Although much has been published on the application of autologous and allogeneic hematopoietic ...
Chitra Hosing
doaj +1 more source
Monitoring of chimerism after allogeneic hematopoietic stem cell transplantation [PDF]
Трансплантология (Москва), 2022 Allogeneic hematopoietic stem cells transplantation is one of the effective methods of treating patients with diseases of the blood system.Establishment of complete (100%) donor chimerism is among of the main indicators of successful transplantation in ...
D. S. Dubnyak +3 more
doaj +2 more sources
Allogeneic hematopoietic stem cell transplantation in mycosis fungoides [PDF]
Anais Brasileiros de Dermatologia, 2013 Mycosis Fungoides is typically an indolent disease in early stages. However, approximately 30% of patients have advanced staged disease at presentation and 20% will develop it at some time. These patients have a poorer prognosis with a median survival of
Angelo Atalla +3 more
doaj +3 more sources
A study on some factors affecting CMV reactivation in allogeneic hematopoietic stem cells transplantation [PDF]
Egyptian Journal of Cancer and Biomedical Research, 2021 Background: In developing countries, cytomegalovirus (CMV) seropositivity has been widely propagated. Following hematopoeitic stem cell transplantation, the apparent risk of CMV reactivation increases.
Metwally Metwally +4 more
doaj +1 more source
Comorbidity Index in Predicting Toxicity and Mortality Risk among patient Undergoing Hematopoietic Stem Cell Transplantation [PDF]
Egyptian Journal of Health Care, 2022 : Despite current improvement in supportive care, mortality after hematopoietic stem cell transplantation remains high. Caring for patients undergoing hematopoietic stem cell transplantation is one of the most challenging in nursing subspecialities. Aim:
Dina Mohamed Maarouf +3 more
doaj +3 more sources
Optimizing Allogeneic Grafts in Hematopoietic Stem Cell Transplantation [PDF]
Stem Cells Translational Medicine, 2021 AbstractAllogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely used in the treatment of hematological diseases. It is well known that allogeneic grafts play a key role in predicting transplantation prognosis. Hematopoietic stem cells (HSCs) are a functional part of grafts and are capable of reconstructing hematopoiesis and immunity ...
Zheng-Li Xu, Xiao-Jun Huang
openaire +3 more sources
Allogeneic hematopoietic stem-cell transplantation for myelofibrosis [PDF]
Therapeutic Advances in Hematology, 2020 Myelofibrosis is one of the Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms with heterogeneous clinical course. Though many treatment options, including Janus kinase (JAK) inhibitors, have provided clinical benefits and improved survival, allogeneic hematopoietic stem-cell transplantation (AHSCT) remains the only potentially curative
Lining Zhang, Fan Yang, Sizhou Feng
openaire +3 more sources
Allogeneic hematopoietic stem cell transplantation in Tunisia [PDF]
Bone Marrow Transplantation, 2008 In 1998, the Tunisian team of the 'Centre National de Greffe de Moelle Osseuse' initiated allogeneic hematopoietic SCT (AHSCT) in Tunisia. As of June 2007, information was collected about 299 patients with a first AHSCT and 12 additional retransplants. The median age was 19 years (range 2-49 years). The main indications were aplastic anemia (n=106, 36%)
T, Ben Othman +7 more
openaire +2 more sources
Donation and transplantation of allogeneic hematopoietic stem cells [PDF]
Canadian Medical Association Journal, 2011 Only 30% of patients with indications for a transplant have a matched related donor; the remaining 70% seek an unrelated donor on the world’s registry. Nonwhite Canadians have a particularly low likelihood of finding a match.1,2 Appendix 1 lists common indications for transplant (available at ...
Ilana, Kopolovic, Robert, Turner
openaire +2 more sources